marine drugs Review Microalgae n-3 PUFAs Production and Use in Food and Feed Industries Marine Remize 1 , Yves Brunel 1, Joana L. Silva 2, Jean-Yves Berthon 3 and Edith Filaire 3,4,* 1 GREENSEA, 3 Promenade du Sergent Jean-Louis Navarro, 34140 MÈZE, France;
[email protected] (M.R.);
[email protected] (Y.B.) 2 ALLMICROALGAE–Natural Products, Avenida 25 Abril, 2445-413 Pataias, Portugal;
[email protected] 3 GREENTECH, Biopôle Clermont-Limagne, 63360 SAINT BEAUZIRE, France;
[email protected] 4 ECREIN Team, UMR 1019 INRA-UcA, UNH (Human Nutrition Unity), University Clermont Auvergne, 63000 Clermont-Ferrand, France * Correspondence: edith.fi
[email protected] Abstract: N-3 polyunsaturated fatty acids (n-3 PUFAs), and especially eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are essential compounds for human health. They have been proven to act positively on a panel of diseases and have interesting anti-oxidative, anti-inflammatory or anti-cancer properties. For these reasons, they are receiving more and more attention in recent years, especially future food or feed development. EPA and DHA come mainly from marine sources like fish or seaweed. Unfortunately, due to global warming, these compounds are becoming scarce for humans because of overfishing and stock reduction. Although increasing in recent years, aquaculture appears insufficient to meet the increasing requirements of these healthy molecules for humans. One alternative resides in the cultivation of microalgae, the initial producers of EPA and DHA. They are also rich in biochemicals with interesting properties. After defining macro and microalgae, this Citation: Remize, M.; Brunel, Y.; review synthesizes the current knowledge on n-3 PUFAs regarding health benefits and the challenges Silva, J.L.; Berthon, J.-Y.; Filaire, E.